TITLE

Reticence to prescribe: utilization of expedited partner therapy among obstetrics providers in Arizona

AUTHOR(S)
Taylor, M. M.; Collier, M. G.; Winscott, M. M.; Mickey, T.; England, B.
PUB. DATE
August 2011
SOURCE
International Journal of STD & AIDS;Aug2011, Vol. 22 Issue 8, p449
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Expedited partner therapy (EPT) is the practice of providing an extra dose or prescription of antibiotic to patients diagnosed with chlamydia or gonorrhoea to deliver to their sexual partner(s). Obstetrical providers who delivered more than 20 infants in Maricopa County, Arizona, USA, during the year 2008 were surveyed by telephone regarding their use of EPT. A total of 142 eligible respondents completed the survey, representing 34% (1 42/421) of the delivering providers, 67 (47%) of whom reported the use of EPT in their clinics. Having received information about EPT was significantly associated with its use (67% versus 41%) (P = 0.008). The most common reasons for not using EPT included the inability to obtain allergy history in partners (24%) and concern for liability (11 %). Additional education regarding the use of EPT may increase the use of this personal and public health tool among some obstetrics providers in Maricopa County; however, concerns for liability may limit broad utilization.
ACCESSION #
66167940

 

Related Articles

  • UK antibiotic now OTC.  // Australian Journal of Pharmacy;Apr2009, Vol. 90 Issue 1067, p3 

    The article reports on the first over-the-counter antibiotic Clamella, launched in Great Britain by Actavis for the tretmant of chlamydia.

  • Antibiotic Susceptibility of Chlamydia pneumoniae. Orfila, Jeanne // Journal of Infectious Diseases;6/15/2000 Supplement 3, Vol. 181, pS455 

    Asserts that chlamydia species are susceptible in vitro to certain antibiotics, and various tetracyclines, macrolides and flouroquinolones are used for the treatment of chlamydia trachomatis infections. Literature about the in vitro susceptibility and chemical response to infection with...

  • Feasibility of Eliminating Ocular Chlamydia trachomatis With Repeat Mass Antibiotic Treatments. Melese, Muluken; Chidambaram, Jaya Devi; Alemayehu, Wondu; Lee, David Chung; Yi, Elizabeth H.; Cevallos, Vicky; Zhou, Zhaoxia; Donnellan, Cathy; Saidel, Michael; Whitcher, John P.; Gaynor, Bruce D.; Lietman, Thomas M. // JAMA: Journal of the American Medical Association;8/11/2004, Vol. 292 Issue 6, p721 

    Context Mass antibiotic administrations for ocular chlamydial infection play a key role in the World Health Organization's trachoma control program. Mathematical models suggest that it is possible to eliminate trachoma locally with repeat mass treatment, depending on the coverage level of the...

  • Azithromycin in the management of Chlamydia trachomatis infections. Ridgway, G. L. // International Journal of STD & AIDS;Jan1996 Supplement 1, Vol. 7, p5 

    The unique pharmacological profile of the azalide macrolide azithromycin, coupled with its in vitro activity against both Chlamydia trachomatis and the ureaplasmas, suggested that genital infections caused by these bacteria could be successfully treated with a single dose of the antibiotic. This...

  • chlortetracycline.  // Royal Society of Medicine: Medicines;2002, p152 

    The article provides information on the drug chlortetracycline. It is a broad-spectrum antibacterial and antibiotic. It can be used to treat many forms of infection including chlamidial infections, especially of the eye and skin. It can be administered topically or orally. Although topical...

  • azithromycin. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p84 

    An encyclopedia entry for "azithromycin" is presented. It refers to a macrolide antibiotic drug used in treating infections of the skin, chest, throat and ears. It is also used to treat infections caused by chlamydia.

  • Unfair decision. Brooks, Dan // Missoula Independent;10/24/2013, Vol. 24 Issue 43, p10 

    No abstract available.

  • Clinical guidelines and standards for the management of uncomplicated genital chlamydial infection. Central Audit Group in Genitourinary Medicine. Fitzgerald, M. R.; Welch, J.; Robinson, A. J.; Ahmed-Jushuf, I. H. // International Journal of STD & AIDS;May1998, Vol. 9 Issue 5, p253 

    The article focuses on the treatment of uncomplicated genital chlamydial infection. Chlamydia is found to be the most frequently occurring sexually transmitted bacterial infection in young sexually active people. The treatment of the disease is dependent not only on the screening of infection...

  • Seven days of doxycycline is an effective treatment for asymptomatic rectal Chlamydia trachomatis infection. Elgalib, A.; Alexander, S.; Tong, C. V. W.; White, J. A. // International Journal of STD & AIDS;Aug2011, Vol. 22 Issue 8, p474 

    There are no evidence-based guidelines for the specific management of rectal chlamydia trachomatis (CT) infection. All men who have sex with men (MSM) diagnosed with asymptomatic rectal CT by nucleic acid amplification test (NAAT) at a large London genitourinary (GU) medicine clinic between...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics